Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 12, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT® FDA Clinical Trial

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...
August 28, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura Medical Strengthens Manufacturing Team in Preparation for SugarBEAT® Commercial Launch.

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by...
August 09, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura Medical Inc. Reports First Quarter 2018 Financial Results

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and...
July 31, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura Initiates US FDA Studies, and Reports Positive Interim Data from Home-Use Portion of Study

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and...